Literature DB >> 30977769

Treatment of Nonmetastatic Breast Cancer.

Kathryn J Ruddy1, Patricia A Ganz2,3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30977769     DOI： 10.1001/jama.2019.3927

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  10 in total

1.  Targeted core-shell nanoparticles for precise CTCF gene insert in treatment of metastatic breast cancer.

Authors:  Jialun Duan; Chunjie Bao; Ying Xie; Haitao Guo; Yixuan Liu; Jianwei Li; Rui Liu; Peishan Li; Jing Bai; Yan Yan; Limin Mu; Xueqi Li; Guiling Wang; Wanliang Lu
Journal:  Bioact Mater       Date:  2021-10-07

2.  Trends in surgical treatment of early-stage breast cancer reveal decreasing mastectomy use between 2003 and 2016 by age, race, and rurality.

Authors:  Mya L Roberson; Hazel B Nichols; Andrew F Olshan; Stephanie B Wheeler; Katherine E Reeder-Hayes; Whitney R Robinson
Journal:  Breast Cancer Res Treat       Date:  2022-03-14       Impact factor: 4.624

3.  Lipidome-based Targeting of STAT3-driven Breast Cancer Cells Using Poly-l-glutamic Acid-coated Layer-by-Layer Nanoparticles.

Authors:  Isidora Tošić; Lisa N Heppler; Susana P Egusquiaguirre; Natalie Boehnke; Santiago Correa; Daniel F Costa; Elizabeth A Grossman Moore; Sharmistha Pal; Douglas S Richardson; Alexander R Ivanov; Daphne A Haas-Kogan; Daniel K Nomura; Paula T Hammond; David A Frank
Journal:  Mol Cancer Ther       Date:  2021-02-03       Impact factor: 6.009

4.  FEN1 is a prognostic biomarker for ER+ breast cancer and associated with tamoxifen resistance through the ERα/cyclin D1/Rb axis.

Authors:  Lu Xu; Ji-Ming Shen; Jing-Lei Qu; Na Song; Xiao-Fang Che; Ke-Zuo Hou; Jing Shi; Lei Zhao; Sha Shi; Yun-Peng Liu; Xiu-Juan Qu; Yue-E Teng
Journal:  Ann Transl Med       Date:  2021-02

5.  A novel targeted multifunctional nanoplatform for visual chemo-hyperthermia synergy therapy on metastatic lymph nodes via lymphatic delivery.

Authors:  Weiwei Liu; Xiaoping Ye; Lingyun He; Juan Cheng; Wenpei Luo; Min Zheng; Yaqin Hu; Wei Zhang; Yang Cao; Haitao Ran; Lu Yang
Journal:  J Nanobiotechnology       Date:  2021-12-20       Impact factor: 10.435

6.  Development and Validation of Ferroptosis- and Immune-Related lncRNAs Signatures for Breast Infiltrating Duct and Lobular Carcinoma.

Authors:  Tao Wei; Ning Zhu; Weihua Jiang; Xiao-Liang Xing
Journal:  Front Oncol       Date:  2022-04-04       Impact factor: 5.738

7.  The Predictive Value of Changes in the Absolute Counts of Peripheral Lymphocyte Subsets for Progression and Prognosis in Breast Cancer Patients.

Authors:  Aqing Liu; Ying Xia; Wentao Li; Guan Zhang; Yunhe Liu; Songshan Ye; Zhijie-Ruo Zhao; Yanjie Yang; Yingjie Jia; Yongtie Guo; Xu Liu; Huayu Chen; Jianchun Yu
Journal:  Contrast Media Mol Imaging       Date:  2022-08-18       Impact factor: 3.009

8.  AUF1 promotes stemness in human mammary epithelial cells through stabilization of the EMT transcription factors TWIST1 and SNAIL1.

Authors:  Manar M AlAhmari; Huda H Al-Khalaf; Falah H Al-Mohanna; Hazem Ghebeh; Abdelilah Aboussekhra
Journal:  Oncogenesis       Date:  2020-08-05       Impact factor: 7.485

9.  Automated Breast Volume Scanner (ABVS)-Based Radiomic Nomogram: A Potential Tool for Reducing Unnecessary Biopsies of BI-RADS 4 Lesions.

Authors:  Shi-Jie Wang; Hua-Qing Liu; Tao Yang; Ming-Quan Huang; Bo-Wen Zheng; Tao Wu; Chen Qiu; Lan-Qing Han; Jie Ren
Journal:  Diagnostics (Basel)       Date:  2022-01-12

Review 10.  Key Factor Regulating Inflammatory Microenvironment, Metastasis, and Resistance in Breast Cancer: Interleukin-1 Signaling.

Authors:  Fengjie Liu; Lihong Li; Meng Lan; Tengteng Zou; Zhaodi Kong; Tiange Cai; Xiao Yu Wu; Yu Cai
Journal:  Mediators Inflamm       Date:  2021-09-23       Impact factor: 4.711
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.